Abstract
High resolution HLA matching at HLA-A, B, C and DRB1 has proven critical for optimal outcomes following unrelated donor (URD) hematopoietic stem cell transplantation (HCT). Approximately 30% of URD HCT facilitated through by the National Marrow Donor Program (NMDP) are mismatched (MM) at one or more loci. Currently, no rating system exists to reliably predict which HLA MM URD should be selected for patients who do not have an HLA allele matched donor. In 2002, Elsner and Blasczyk suggested that a rating system, HistoCheck, might be used to identify acceptable MM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
